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Francis Tinney, MD,1 Tommy Ivanics, MD,1 Joel Stracke, DO,2 Lauren Malinzak, MD,1 Ahmed M. Elsabbagh, MD,3
Tracci McEvoy, PA,1 Shunji Nagai, MD,1 and Atsushi Yoshida, MD1

Background. Living donor robotic-assisted kidney transplantation (RAKT) is an alternative to open kidney transplantation (OKT), but experience with this technique is limited in the United States. Methods. A retrospective review of living
donor kidney transplants performed between 2016 and 2018 compared RAKT with OKT with regard to recipient, donor, and
perioperative parameters. A 1:1 propensity score matching was performed on recipient/donor age, sex, body mass index,
race, preoperative dialysis, and calculated panel reactive antibodies. Results. Outcomes of patient survival, graft survival,
and postoperative complications were assessed for 139 transplants (47 RAKT and 92 OKT). Propensity score analysis
(47:47) showed that RAKT recipients had longer warm ischemic times (49 versus 40 min; P < 0.001) and less blood loss (100
versus 150 mL; P = 0.005). Operative time and length of stay were similar between groups. Postoperative serum creatinine
was similar during a 2-y follow-up. Post hoc analysis excluding 4 open conversions showed lower operative time with RAKT
(297 versus 320 min; P = 0.04) and lower 30-d (4.7% versus 23.4%; P = 0.02) and 90-d (7% versus 27.7%; P = 0.01) ClavienDindo grade ≥3 complications. Conclusions. Our findings suggest that RAKT is a safe alternative to OKT.
(Transplantation Direct 2022;8: e1320; doi: 10.1097/TXD.0000000000001320).

INTRODUCTION
Although minimally invasive surgery has replaced much
of our traditional open surgical procedures within most
surgical specialties, such approaches in transplantation
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remain novel. Outside of laparoscopic donor nephrectomy1 and donor hepatectomy,2 few transplant procedures
widely use minimally invasive procedures. With newer
technology, there is opportunity to reimagine certain procedures. Robotic-assisted surgery provides advantages
over standard laparoscopic surgery, such as high-definition
3D imaging, increased magnification and camera stability, and articulation of instruments aiding in suturing. As
access to these devices is limited at many institutions, their
use in transplantations was initiated with robotic-assisted
donor nephrectomy. Enhanced ergonomics, improved outcomes, and shorter length of stay resulting from minimally
invasive surgical approaches have been shown by several
centers.3-5
Initial and follow-up reports by Oberholzer et al6 have
revealed that the advent of robotic-assisted kidney transplant
(RAKT) has increased the accessibility of kidney transplantation for obese patients, although minimizing morbidity. The
da Vinci surgical system (Intuitive Surgical, Sunnyvale, CA)
was first used as an adjunct to open kidney transplantation
(OKT) by Hoznek et al7 in 2001, where this group completed
a hybrid procedure with an open incision and robotic-assisted
dissection, isolation of vessels, and anastomosis, with an
assistant providing retraction. This was followed up in 2009
when Giulianotti et al8 described an RAKT performed on an
obese man, where surgeons used a hand-assisted technique to
manipulate the graft intracorporeally. In 2013, Menon et al9,10
published research describing a nonhand-assisted technique
www.transplantationdirect.com
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for implantation for all patients, providing an alternative
approach for robotic kidney transplants. Although several
centers in Europe have used the nonhand-assisted approach,11
there is a dearth of experience with this approach in the heterogeneous US population. Furthermore, there is a lack of data
directly comparing perioperative and postoperative outcomes
between RAKT and OKT.
Given increased interest in RAKT, we evaluated the shortterm and long-term outcomes of patients undergoing living
donor RAKT and OKT by performing a propensity scorematched analysis in an early series of RAKT. As with other
minimally invasive procedures, we assessed the effect of
RAKT on length of hospital stay and opioid use during the
study time frame.

MATERIALS AND METHODS
Study Design and Patient Population
A retrospective record review analysis of all living donor
kidney transplants performed at Henry Ford Hospital in
Detroit, Michigan, between January 2016 and December
2018 was conducted after approval by the Henry Ford
Hospital Institutional Review Board (12269). Robotic kidney transplants began in 2014, and 8 RAKTs were performed
through the end of 2015. To minimize bias from initial cases,
we selected a cohort from January 2016 to December 2018.
The determination of which patients received RAKT was predominantly based on da Vinci robot availability and no other
parameters. Living donor kidney transplants were grouped
according to the initial surgical approach (OKT or RAKT).
The inclusion criteria included the following: irreversible
renal disease (symptomatic patients with glomerular filtration rate <20 mL/min or the need for dialysis), age ≥18 y old,
absence of significant cardiovascular disease, and avoidance
of complex vascular anatomy (>2 arteries or >2 veins). The
exclusion criteria for a robotic kidney transplant were the following: previous transplant, complex abdominal surgeries,
autosomal dominant polycystic kidney disease, or significant
aortoiliac disease. A total of 128 (92.1%) patients completed
a follow-up period of at least 2 y after transplant. The median
follow-up time for the entire cohort was 37.3 mo (interquartile range [IQR] 29.3–46.7).
Surgical Procedure
All donor kidneys were procured from living donors via
minimally invasive donor nephrectomy, which included pure
laparoscopic, hand-assisted laparoscopic, and robotic-assisted
laparoscopic donor nephrectomy. Recipient operations were
generally staggered, with occasional procedures performed
sequentially. All organs were flushed and stored in histidinetryptophan-ketoglutarate solution before implantation.
Robotic operations were performed using the da Vinci
Si, X, or Xi Surgical Systems (Intuitive Surgical). The cases
were performed primarily by 2 senior surgeons, 1 who had
extensive experience in robotic surgery and the second who
was trained throughout the duration of the study period. The
RAKT technique was previously described by Menon et al10
in the IDEAL phase 2a study. Specific modifications of that
procedure include the use of the curved robotic scissors to
perform the arteriotomy with a cruciate incision and the use
of 5-0 PDS (Ethicon, Somerville, NJ) sutures for ureteroneocystostomy (modified Lich-Gregoir technique). Periumbilical
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incisions were generally <6 cm and modified according to kidney size. All anastomoses were performed with 6-0 GORETEX (Gore Medical, Flagstaff, AZ) sutures. The back-table
preparation was completed in standard fashion with care
to ligate any possible source of bleeding. Kidneys were then
wrapped in ice-gauze jackets with marking stitches to maintain orientation before implantation.
OKTs were performed following standard retroperitoneal
technique via Gibson incision. Renal artery and renal vein
anastomoses were performed with 6-0 PROLENE (Ethicon,
Somerville, NJ) sutures using 2.5-magnification loupes.
Ureteroneocystostomy was performed using the modified
Lich-Gregoir technique with 5-0 PDS sutures.
Irrespective of operative technique, all patients received triple immunosuppression therapy. Induction was either basiliximab or antithymocyte globulin (Thymoglobulin), per Henry
Ford Hospital Protocol.
Study Variables and Outcomes
Data for sociodemographic variables, surgical and functional outcomes, and early postoperative complications with
a minimum follow-up of 90 d were retrospectively collected.
Furthermore, we calculated a Charlson Comorbidity Index
for each patient, an algorithm used to measure patients’
comorbid disease status.12 Perioperative variables included
warm ischemia time (WIT), cold ischemia time, extraperitoneal versus intraperitoneal implantation, estimated blood
loss, operative time, and induction and maintenance immunosuppression. Total operative time was calculated from
case start (ie, incision time) until case end (ie, closure), as
tracked by nursing staff in the electronic medical record. This
included back-bench time and any additional time waiting for
donor nephrectomy to be completed. Delayed graft function
was defined as the need for dialysis within a week following transplantation. The functional parameter evaluated was
serum creatinine (SCr) on postoperative days (POD) 7, 14,
180, 1 y, and 2 y. Patient and graft survival were assessed
at 1 y, 2 y, and overall posttransplant. Additionally, analgesic
requirements administered (morphine equivalents) and length
of hospital stay were analyzed. Opioid utilization was calculated using a standard conversion chart to tabulate total oral
morphine equivalents consumed. Postoperative complications
were recorded 30 and 90 d after transplant and included ileus
(defined as requiring placement of a nasogastric tube for gastric decompression), need for any blood product transfusion,
and need for vascular and ureteral interventions. The latter
included urinary leaks and ureteral obstruction. Postoperative
complications occurring within 30 and 90 d of the transplant
were graded using the Clavien-Dindo classification system.13
Propensity Score Matching
A propensity score was constructed using logistic regression and was based on the predicted probability of receiving
an RAKT.14 This analysis was performed to control for the
effect of confounding variables and represents a method for
addressing selection bias. Covariates selected were ones that
may have influenced the decision for the type of procedure
(OKT versus RAKT) and therein represent a source of potential selection bias. These included recipient age, sex, body
mass index, race, preemptive dialysis, diabetes mellitus, calculated panel reactive antibodies, and donor age. Matching was
then performed using these covariates in a 1:1 ratio between

© 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
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RAKT and OKT using an optimal matching method. This
matching method finds the matched samples with the smallest
average absolute distance across the matched pairs. Matching
quality and covariate balance were evaluated with standardized mean differences between the treated and control groups.
A difference of <0.2 standardized mean difference between
covariates was used as indicative of a negligible imbalance
between groups.14 Final groups comprised 47 patients each. A
sensitivity analysis using an additional matched RAKT versus
OKT cohort was performed, excluding RAKT cases requiring
conversions. This was referred to as “per-protocol” analysis.
Statistical Analysis
Descriptive data for continuous variables were expressed as
medians and IQR for nonnormally distributed variables and
compared using the Mann-Whitney U test. Categorical variables were expressed as number and percentage and were compared using chi-square and Fisher exact tests. Overall survival
was estimated using the Kaplan-Meier method, and groups
were compared via log-rank tests. After matching, a univariable Cox proportional hazard model was used to evaluate the
exposure hazard (surgical approach) on the outcome of death.
For graft survival analysis, rather than the Kaplan-Meier
method, which censors for the competing event of death, a
cumulative incidence approach was used to account for the
presence of a competing risk of death with graft failure.15 The
cumulative incidence was calculated using subdistribution estimates for each cause, and a Gray modified log-rank test was
used to compare subdistribution estimates. To assess for the
relative change in the hazard of graft failure, a Fine-Gray proportional subdistribution hazard model was used to account
for death as a competing event.16 A P value of <0.05 was considered statistically significant. Statistical analyses were performed using R (R version 4.0.2 [2020-06-22], R Foundation
for Statistical Computing, Vienna, Austria). Matching was performed using the MatchIt and Optmatch packages.
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RESULTS
Overall Cohort: Patient Characteristics
A total of 139 patients who received kidney transplantation (47 RAKT; 92 OKT) was identified in the study period.
Although not significantly different, the OKT group comprised older recipients (median [IQR], 54 [43–63] versus 48
[36–60] y; P = 0.07). Of the 92 patients who received OKT,
71% were White, 19% were Black, and 11% had “other”
listed in the medical record. Of the 47 patients who received
RAKT, 47% were White, 36% were Black, and 17% had
“other” listed in the medical record. Of the patients who
required dialysis before the kidney transplant, the duration
of dialysis was longer in the RAKT group (median [IQR], 14
[6–22] versus 24 [9–32] mo; P = 0.04) (Table 1).
Overall Cohort: Perioperative Factors
A higher proportion of ureteral stents were placed in the
RAKT group (68.5 versus 95.7%; P = 0.001). Ureteral stents
were placed in nearly all of the RAKT patients, as was standard of care during the study period. The decision to place ureteral stents in OKT patients was dependent upon individual
surgeon preference. Left-sided donor nephrectomy was completed in all patients except for 1 patient in the OKT group.
Implantation occurred on the right side in 100% (47/47) of
patients in the RAKT group and 79% (73/92) of patients
in the OKT group. The median operative time was similar
between the groups (median [IQR], OKT 313 [273–349] versus RAKT 299 [261–325] min; P = 0.10). The RAKT group
had longer median WIT in minutes (median [IQR], 40 [34–
48] versus 49 [43–53] min; P < 0.001). The median estimated
blood loss was lower in the RAKT group (median [IQR], 150
[100–200] versus 100 [50–150] mL; P = 0.004) (Table 2).
RAKT Requiring Conversion to OKT
Conversion to an open approach was required in 4
robotic procedures (9%). All 4 patients had good renal

TABLE 1.

Propensity score matching, patient characteristics
Before matching
Characteristic
Recipient age, median (IQR)
Recipient male sex, N (%)
Recipient race, N (%)
White
Black
Other
Recipient body mass index, kg/m2, median (IQR)
Diabetes mellitus, N (%)
Recipient PRA
0–20 (not sensitized)
(20–80) sensitized
>80 (highly sensitized)
Preemptive dialysis, N (%)
Preemptive
Hemodialysis
Peritoneal dialysis
Duration of dialysis, mo, median (IQR)
Donor age, median (IQR)

OKT n = 92
(66.2%)

RAKT n = 47
(33.8%)

54 (43–63)
62 (67.4)

48 (36–60)
31 (66.0)

65 (70.7)
22 (46.8)
17 (18.5)
17 (36.2)
10 (10.9)
8 (17.0)
28.1 (24.6–31.2) 29.6 (25.0–33.6)
35 (38.0)
16 (34.0)
80 (87.0)
12 (13.0)
0 (0.0)

40 (85.1)
6 (12.8)
1 (2.1)

29 (31.5)
44 (47.8)
19 (20.7)
14 (6–22)
43 (33–52)

14 (29.8)
22 (46.8)
11 (23.4)
24 (9–32)
40 (30–52)

After matching
P

SMD

0.07
1.00
0.02

0.34
0.03
0.50

0.40
0.78
0.37

0.12
0.08
0.21

OKT n = 47
(50%)

RAKT n = 47
(50%)

50 (40–60)
31 (66.0)

48 (36–60)
31 (66.0)

23 (48.9)
14 (29.8)
10 (21.3)
28.4 (24.4–34.2)
12 (25.5)
39 (83.0)
8 (17.0)
0 (0.0)

0.93

0.04
0.41

0.07

0.24
0.15

14 (29.8)
24 (51.1)
9 (19.1)
14 (7–25)
43 (33–51)

P

SMD

0.60
0.09
1.00 <0.001
0.77
0.15

22 (46.8)
17 (36.2)
8 (17.0)
29.6 (25.0–33.6) 0.96
0.02
16 (34.0)
0.50
0.19
0.52
0.24
40 (85.1)
6 (12.8)
1 (2.1)
1.00 <0.001
14 (29.8)
22 (46.8)
11 (23.4)
24 (9–32)
0.16 –0.09
40 (30–52)
0.39
0.15

IQR, interquartile range; OKT, open kidney transplantation; PRA, panel reactive antibodies; RAKT, robotic-assisted kidney transplantation; SMD, standard mean difference.
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TABLE 2.

Propensity score matching, perioperative factors
Before matching
Perioperative factors
Induction, N (%)
None
Thymoglobulin
Simulect
Number of arteries, N (%)
1
2
3
Operative time in min, median (IQR)
CIT in min, median (IQR)
WIT in min, median (IQR)
Estimated blood loss, mL, median (IQR)
Graft function, N (%)
Immediate
Delayed
POD 1 morphine equivalent, median (IQR)
POD 2 morphine equivalent, median (IQR)

OKT n = 92
(66.2%)

After matching

RAKT n = 47
(33.8%)

13 (14.1)
25 (27.2)
54 (58.7)

P

SMD

0.24

0.30

4 (8.5)
19 (40.4)
24 (51.1)
0.67

72 (78.3)
19 (20.7)
1 (1.1)
313 (273–349)
76 (57–107)
40 (34–48)
150 (100–200)

39 (83.0)
8 (17.0)
0 (0.0)
299 (261–325)
77 (60–112)
49 (43–53)
100 (50–150)

80 (87.0)
1 (1.1)
33 (21–54)
20 (10–45)

44 (93.6)
3 (6.4)
38 (19–60)
23 (8–42)

0.10
0.99
<0.001
0.004
0.23

0.53
0.76

OKT n = 47
(50%)

RAKT n = 47
(50%)

6 (12.8)
16 (34.0)
25 (53.2)

4 (8.5)
19 (40.4)
24 (51.1)

0.18

0.34
0.17
0.82
0.33
0.23

0.16
0.04

36 (76.6)
10 (21.3)
1 (2.1)
314 (275–354)
76 (55–117)
40 (34–49)
150 (100–200)

39 (83.0)
8 (17.0)
0 (0.0)
299 (261–325)
77 (60–112)
49 (43–53)
100 (50–150)

42 (89.4)
5 (10.6)
39 (25–59)
32 (11–53)

44 (93.6)
3 (6.4)
38 (19–60)
23 (8–42)

P

SMD

0.71

0.17

0.51

0.24

0.07
0.88
<0.001
0.03
0.71

0.41
0.24
0.72
0.22
0.15

0.54
0.31

0.09
0.07

CIT, cold ischemia time; IQR, interquartile range; OKT, open kidney transplantation; POD, postoperative day; RAKT, robotic-assisted kidney transplantation; SMD, standard mean difference; WIT, warm
ischemia time.

TABLE 3.

RAKT cases requiring conversion to OKT
Case 1: In this case, shortly after normal reperfusion, the kidney became cyanotic; therefore, the decision was made to convert to an open approach, made through a
midline incision. The kidney was twisted, which raised a concern of arterial intimal injury and possible thrombus; thus, the arterial anastomosis was revised.
Case 2: In this case, conversion to an open approach occurred because of early high bloody drain output following closure, although the patient was still in the operating room;
negative exploratory laparotomy was performed; subsequent irrigation of Foley catheter found multiple clots with clot retention, with urine output improved.
Case 3: In this case, conversion to open approach occurred at the beginning of the operation because of significant adhesions from a previous exploratory laparotomy for a
gunshot wound, preventing insufflation.
Case 4: In this case, conversion to an open approach occurred because of a twist of the renal vein, which required removal of the kidney, repeat cold-perfusion, and repeat anastomoses.
OKT, open kidney transplantation; RAKT, robotic-assisted kidney transplantation.

TABLE 4.

Propensity score matching, patient outcomes
Before
Patient outcomes
LOS in days, median (IQR)
Preoperative SCr, median (IQR)
SCr (1 wk)
SCr (2 wk)
SCr (6 mo)
SCr (1 y)
SCr (2 y)
Follow-up, mo (IQR)
30-d readmission, N (%)
90-d readmission, N (%)
Conversion to open, N (%)
Ileus, N (%)
Ureteral complications, N (%)
Reoperation, N (%)
Transfusion, N (%)
Lymphocele drain placement, N (%)
Hernia, N (%)
Clavien ≥3 (30 d), N (%)
Clavien ≥3 (90 d), N (%)

After

OKT n = 92
(66.2%)

RAKT n = 47
(33.8%)

P

SMD

4 (3–6)
6.0 (4.2–8.7)
1.5 (1.1–2.2)
1.4 (1.1–1.9)
1.3 (1.1–1.7)
1.3 (1.1–1.6)
1.2 (1.1–1.7)
38.0 (29.3–47.2)
24 (26.1)
25 (27.2)
–
4 (4.3)
5 (5.4)
6 (6.5)
3 (3.3)
6 (6.5)
1 (1.1)
18 (19.6)
21 (22.8)

3 (3–5)
6.0 (4.7–9.2)
1.6 (1.3–2.1)
1.5 (1.2–2.0)
1.4 (1.2–1.7)
1.3 (1.1–1.7)
1.5 (1.2–1.7)
36.6 (29.4–45.2)
11 (23.4)
14 (29.8)
4 (8.5)
3 (6.4)
3 (6.4)
1 (2.1)
0 (0.0)
0 (0.0)
1 (2.1)
5 (10.6)
6 (12.8)

0.08
0.94
0.20
0.22
0.27
0.62
0.13
0.55
0.89
0.90
–
0.91
1.00
0.48
0.53
0.18
1.00
0.27
0.23

0.36
0.01
0.16
0.17
0.24
0.07
0.19
0.15
0.06
0.06
–
0.09
0.04
0.22
0.26
0.37
0.08
0.25
0.27

OKT n = 47
(50%)
4 (3–6)
7.4 (5.6–9.0)
1.5 (1.1–2.4)
1.3 (1.1–2.0)
1.3 (1.1–1.7)
1.3 (1.1–1.6)
1.2 (1.1–1.7)
40.2 (31.4–46.3)
12 (25.5)
11 (23.4)
–
3 (6.4)
3 (6.4)
4 (8.5)
2 (4.3)
5 (10.6)
1 (2.1)
11 (23.4)
13 (27.7)

RAKT n = 47
(50%)
3 (3–5)
6.0 (4.7–9.2)
1.6 (1.3–2.1)
1.5 (1.2–2.0)
1.4 (1.2–1.7)
1.3 (1.1–1.6)
1.5 (1.2–1.7)
36.6 (29.4–45.2)
11 (23.4)
14 (29.8)
4 (8.5)
3 (6.4)
3 (6.4)
1 (2.1)
0 (0.0)
0 (0.0)
1 (2.1)
5 (10.6)
6 (12.8)

IQR, interquartile range; LOS, length of stay; OKT, open kidney transplant; RAKT, robotic kidney transplant; SCr, serum creatinine; SMD, standard mean difference.

P

SMD

0.11
0.21
0.62
0.40
0.27
0.77
0.18
0.23
1.00
0.64
–
1.00
1.00
0.36
0.48
0.07
1.00
0.17
0.12

0.40
0.20
0.09
0.18
0.25
0.07
0.34
0.29
0.05
0.15
–
<0.001
<0.001
0.29
0.30
0.49
<0.001
0.35
0.38

© 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

function at 1 y, with SCr levels of 0.9 mg/dL, 1.4 mg/dL,
1.1 mg/dL, and 1.7 mg/dL. Please refer to Table 3 for a
description of cases.
Overall Cohort: Posttransplant Outcomes
Length of stay was similar between groups (median
[IQR], 4 [3–6] versus 3 [3–5] d; P = 0.08), as were SCr levels at up to 2 y posttransplantation. In addition, there were
similar rates of readmission, reinterventions, and postoperative complications (Table 4). The cumulative incidence
of graft failure was similar (at 1 y [95% CI], OKT 0%
[0-0] versus RAKT 0% [0-0], P = 0.17; at 2 y, OKT 1.1%
[0.1-5.3] versus RAKT 0% [0-0], P = 0.22; at 3 y, OKT
2.4% [0.5-7.7] versus RAKT 7.9% [1.9-19.6], P = 0.22;
and at 4 y, OKT 7.9% [2.2-18.5] versus RAKT 7.9%
[1.9-19.6], P = 0.57; overall Gray’s modified log-rank test
P = 0.56) (Figure 1). Similarly, patient survival was equivalent between the groups >4 y (at 1 y [95% CI], OKT 100%
[100-100] versus RAKT 97.9% [93.8-100], P = 0.16; at

Tinney et al

5

2 y, OKT 98.9% [96.8-100] versus RAKT 97.9% [93.8100], P = 0.63; at 3 y, OKT 94.9% [89.4-100] versus RAKT
95.6% [89.8-100], P = 0.79; and at 4 y, OKT 94.9% [89.4100] versus RAKT 80.0% [61.2-100], P = 0.17; overall logrank P = 0.17) (Figure 2).
Matched Cohort: Patient Characteristics
After 1:1 propensity score matching, 47 patients were
included in each group. After matching, the 2 groups were
similar in recipient age, sex, ethnicity, body mass index,
comorbidities, preoperative renal replacement therapy, calculated panel reactive antibodies, donor age, and cold ischemia
time (Table 1). Additional variables have been listed in Table
S1 (SDC, http://links.lww.com/TXD/A418).
Matched Cohort: Perioperative Factors
The matched RAKT group had lower estimated blood
loss (median [IQR], 150 [100–200] versus 100 [50–150] mL;
P = 0.03). The matched OKT group had shorter WIT than the

FIGURE 1. Four-year cumulative incidence of graft failure (before matching).
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RAKT group (median [IQR], 40 [34–49] versus 49 [43–53]
min; P < 0.001) (Figure 3). There were also significantly fewer
ureteral stents placed in the OKT group (29 [61.7%] versus
45 [95.7%]; P < 0.001) (Table 2). There was no significant
difference between the groups regarding overall operative
time or morphine equivalents prescribed on POD 1 or POD
2 (Table 2).
Matched Cohort: Posttransplant Outcomes
There was no significant difference between the matched
groups in length of stay, 30-d readmissions, or 90-d readmissions. Postoperative SCr was equivalent at 1 wk, 2 wks, 6 mo,
1 y, and 2 y. There were no significant differences between
the matched groups in complications, including ileus, ureteral
complications, transfusions, image-guided drain placement,
hernia, reintervention/reoperation at 30 or 90 d, and ClavienDindo grade ≥3 complications at 30 and 90 d (Table 4; see
Table S5, SDC, http://links.lww.com/TXD/A418). The cumulative incidence of graft failure was equivalent between the
groups (at 1 y, OKT 0% versus RAKT 0%, P = 0.32; at 2

FIGURE 2. Four-year patient survival (before matching).

www.transplantationdirect.com

y, OKT 0% versus RAKT 0%, P = 0.08; at 3 y, OKT 0%
versus RAKT 7.9%, P = 0.08; and at 4 y, OKT 5.0% versus
RAKT 7.9%, P = 0.27; overall Gray’s modified log-rank test
P = 0.28). The robotic approach resulted in a similar subdistribution hazard of graft failure (Fine-Gray subdistribution
hazard ratio for graft failure reference: open, 3.1, 95% CI,
0.33-28.74; P = 0.32) (Figure 4). Patient survival was equivalent between the groups up to 3 y (at 1 y, OKT 100% versus RAKT 97.9%, P = 0.32; at 2 y, OKT 100% versus RAKT
97.9%, P = 0.32; and at 3 y, OKT 100% versus RAKT 95.6%,
P = 0.32). The matched RAKT group had a significantly lower
survival at 4 y posttransplant (at 4 y, OKT 100% versus
RAKT 80.0%; overall log-rank P = 0.04) (Figure 5).
Matched Cohort: Posttransplant Outcomes
(Excluding Converted Cases)
After excluding RAKT cases that had converted to an
open approach, RAKT demonstrated a significant advantage
over OKT for reintervention/reoperation at 30 d (23.3%
versus 4.7%; P = 0.03), reintervention/reoperation at 90 d
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FIGURE 3. Distribution of warm ischemia time by approach. WIT, warm ischemia time.

(30.2% versus 7.0%%; P = 0.01), Clavien-Dindo grade ≥3
complications at 30 d (23.3% versus 4.7%; P = 0.03), and
Clavien-Dindo grade ≥3 complications at 90 d (30.2% versus
7.0%; P = 0.01) (Table S4, SDC, http://links.lww.com/TXD/
A418). The cumulative incidence of graft failure was equivalent between the groups (at 1 y, OKT 0% versus RAKT 0%,
P = 0.32; at 2 y, OKT 0% versus RAKT 0%, P = 0.32; at 3 y,
OKT 2.6% versus RAKT 8.7%, P = 0.32; and at 4 y, OKT
8.0% versus RAKT 8.7%, P = 0.61; overall Gray’s modified
log-rank test P = 0.57). The robotic approach had a similar
subdistribution hazard of graft failure (Fine-Gray subdistribution hazard ratio for graft failure reference: open approach
subdistribution hazard ratio 1.5, 95% CI, 0.26-9.00; P = 0.63)
(Figure S1, SDC, http://links.lww.com/TXD/A418). Similarly,
1-, 2-, and 3-y patient survival was equivalent between the
groups (at 1 y, OKT 100% versus RAKT 97.7%, P = 0.32;
at 2 y, OKT 100% versus RAKT 97.7%, P = 0.63; and at 3
y, OKT 100% versus RAKT 95.2%, P = 0.17). The RAKT
group had a significantly lower survival at 4 y posttransplant
(at 4 y, OKT 100% versus RAKT 77.7%; overall log-rank
P = 0.03) (Figure S2, SDC, http://links.lww.com/TXD/A418).
Additional information regarding patient characteristics and
perioperative factors for matched cohort (excluding converted cases) can be found in Tables S2 and S3 (SDC, http://
links.lww.com/TXD/A418).

DISCUSSION
We have described outcomes in a propensity-matched
cohort of kidney transplant patients who were followed for
at least 2 y after having had transplant surgery with either
RAKT or OKT. We observed equivalence between the groups
in postoperative SCr, length of stay, and 30-d and 90-d
readmissions. After rematching and excluding RAKT cases

requiring open conversion (per-protocol patients), the RAKT
group had lower rates of Clavien-Dindo grade ≥3 complications at both 30 and 90 d after transplantation. Additionally,
the RAKT group had lower rates of reoperation and reintervention at both 30 and 90 d, as well as lower estimated blood
loss. The OKT group had shorter WIT than the RAKT group
but equivalent operative time and postoperative pain control
(ie, morphine equivalents administered).
A higher proportion of ureteral stents was placed in
the RAKT group. The decision to place a stent is based
on surgeon preference. In our current practice, stents are
intermittently placed in RAKT. The difference in WIT was
principally because of placement and alignment of the kidney before anastomosis, which takes approximately 10 min.
The equivalent intention-to-treat and improved per-protocol
outcomes with RAKT demonstrate its potential as an alternative to OKT.
A discussion of the 4 early cases where RAKT required
conversion to a traditional open approach is critical. The post
hoc analysis included matching on RAKT patients who did
not require conversion to open procedure. In this, the RAKT
group demonstrated clear advantages in perioperative complications (eg, Clavien-Dindo grade ≥3 complications at both
30 and 90 d, reoperation/reintervention at both 30 and 90 d).
The intention-to-treat analysis represents a real-life scenario,
as conversions are occasionally unavoidable. They also reflect
a learning curve. The per-protocol thus represents the bestcase scenario if patients receive their intended therapy. It is
conceivable that, with an increase in procedural experience,
the rate of conversions will decrease and afford patients the
benefits of the robotic approach.
This investigation is unique in the heterogeneous population sample, unlike other international references and the
published US experience focusing on an obese population
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FIGURE 4. Four-year cumulative incidence of graft failure (after matching).

group.17 Our study used propensity score matching to compare open versus robotic kidney transplantation, including
analysis from an intention-to-treat standpoint. Using propensity score matching developed variable-matched comparison
groups to adjust for potential confounders that are likely to
affect outcomes and procedure choice. Consequently, this
adjustment can decrease the impact of such confounding variables by homogenizing the cohort to improve the evaluation
of the surgical approach’s impact on short- and long-term
postoperative outcomes. Our findings align with previous literature, demonstrating early advantages of a robotic
approach. To date, multiple investigations have demonstrated
comparable outcomes for death-censored graft survival and
patient survival when comparing conventional OKT to minimally invasive kidney transplant,18 as well as open (Gibson
incision) with RAKT6; however, reports assessing minimally invasive techniques have suggested lower surgical site

infection6 and reduced incisional hernia rates18 with improved
cosmetic results19 and postoperative pain.20,21 Disadvantages
included prolonged WIT20 and total operation time.18-20 We
found lower rates of Clavien-Dindo grade ≥3 complications
at both 30- and 90-d postsurgery in the RAKT group after
propensity score matching. This finding is consistent with previous reports in kidney transplants and also in line with other
comparisons of minimally invasive techniques with open
equivalents in other surgical procedures.22,23
Of note, we observed significantly lower 4-y patient survival in the RAKT group after propensity score matching. The
reason for the long-term difference in survival between the
groups is not clear, but it is unlikely to be related to the surgical procedure itself, given that the patient survival at 1 y and
at 2 y was equivalent and the overall incidence of graft failure
was the same as well. It is possible that there may be differences between the groups in terms of confounding factors that

© 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Tinney et al

9

FIGURE 5. Four-year patient survival (after matching).

were not included in the match that may explain the discrepancy in long-term survival. These could include differences in
the distribution of both type and severity of comorbidities,
such as cardiorespiratory diseases. Consequently, these variables may represent sources of unmeasured confounding.
Improved perioperative pain control is often described as
an advantage of minimally invasive techniques, including
RAKT.20,21 Our analysis did not reveal a statistically significant difference in morphine equivalents administered postoperatively; however, we did see a nonsignificant trend toward
reduced morphine equivalents administered on the second
POD in the RAKT group. Notably, morphine equivalents consumed may not accurately reflect a patient’s level of pain, as
multiple factors may influence administration of narcotics in
the postoperative period, including but not limited to patients’
preoperative opioid use, patients’ pain threshold, and nursing opioid administration practices. Additionally, as kidney
transplant patients are typically discharged home on the third
or fourth POD at our institution, an analysis of long-term
benefits in pain control remains challenging to assess. We did

find a nonsignificant trend toward a reduced length of stay in
the RAKT group, which may indicate improved perioperative
pain control. Future investigations may benefit from analysis
of narcotics consumed after discharge date. Additionally, preoperative education regarding the advantages of a minimally
invasive approach and the expected narcotic requirements in
the perioperative period may further reduce narcotic requirements following transplant.
However, limitations preventing the widespread clinical
application of RAKT as an alternative to OKT exist. Ganpule
et al24 suggested that the cost and logistical complexity of
robotic surgery might stymie implementation within existing
transplant programs and expansion into the deceased donor
population. Although the feasibility of RAKT in deceased
donors has been demonstrated at other institutions,6-8,11,25 we
chose to limit our experience to living donors because of the
ease of logistical complexity of establishing operative block
time with trained personnel. RAKT was first adopted at our
institution in 2014, and the number of cases has increased
over time, from 5 in 2014 to 27 in 2019. Currently, the
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robotic-assisted approach represents approximately 40% of
our living donor kidney transplants. In 2016, we established
a robotic block time in the operating room schedule, allowing
involvement of fellows and other staff surgeons. Additionally,
patient selection is based on robot availability, allowing for
a heterogeneous population and reduced selection bias. As
value-based health care is pushed to the forefront, a cost-analysis of RAKT in the living donor population must be explored.
Furthermore, with the expanded use of robotic-assisted techniques in general surgery, an analysis of the learning curve
required to master complex procedures like renal implantation is warranted. With expanded knowledge of cost-efficacy
and technical mastery, the use of RAKT in the deceased donor
population may offer a future avenue of development.
This study adds to a body of evidence supporting use of
minimally invasive kidney transplantation techniques as
equivalent to traditional open approaches regarding graft survival and patient survival and as potentially superior in terms
of perioperative morbidity. It lays the groundwork for future
exploration into the benefits of robotic-assisted techniques
in solid-organ transplantation. In the future, a nationalized
database of robotic-assisted cases would aid future comparisons of minimally invasive approaches to traditional open
cases. A randomized controlled trial assessing the differences
between open and minimally invasive approaches would
provide a more definitive comparative evaluation of the
impact on short- and long-term outcomes of each approach.
Additionally, as more programs integrate RAKT, analysis of
the learning curve necessary to gain proficiency with the technique will aid understanding of successful implementation.25
This study is limited by its retrospective and nonrandomized
study design, with the potential for selection bias. Resulting
from the single-institutional nature of the study, results may
not be directly generalizable to other centers. Although the
study sample represents the largest North American singleinstitution comparison of RAKT and OKT in nonobese
recipients, the study sample is relatively small, limiting the
study’s statistical power to detect differences between examined groups. Despite covariate adjustment using propensity
score matching, the potential for residual confounding and
type 1 error remains. This is an early experience, and the small
sample size limits the ability to detect individual differences in
graft survival and patient outcomes. Overall, the similarities
are notable, as the experience with RAKT is limited compared
with OKT.
In conclusion, this study compared RAKT to OKT
within a heterogeneous study population using propensity
scoring, the first of its kind in the United States. Despite the
significantly longer WIT with RAKT, we found that SCr in
the early and intermediate RAKT postoperative period was
equivalent to that for OKT. Moreover, length of stay, graft
survival, and patient survival were equivalent between the
groups. Reoperation or reintervention and Clavien-Dindo
grade ≥3 perioperative complication rates were lower in
the RAKT group. As a novel technique with an associated
learning curve, RAKT represents a feasible and safe technique for living donor kidney transplantation. The combination of reduced short-term complication rates and
equivalent long-term outcomes favors the robotic approach
when feasible.
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